AU648842B2
(en)
*
|
1990-09-21 |
1994-05-05 |
Amgen, Inc. |
Enzymatic synthesis of oligonucleotides
|
US5645987A
(en)
*
|
1990-09-21 |
1997-07-08 |
Amgen Inc. |
Enzymatic synthesis of oligonucleotides
|
US5683874A
(en)
*
|
1991-03-27 |
1997-11-04 |
Research Corporation Technologies, Inc. |
Single-stranded circular oligonucleotides capable of forming a triplex with a target sequence
|
US6261808B1
(en)
|
1992-08-04 |
2001-07-17 |
Replicon, Inc. |
Amplification of nucleic acid molecules via circular replicons
|
US6096880A
(en)
*
|
1993-04-15 |
2000-08-01 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
US7135312B2
(en)
|
1993-04-15 |
2006-11-14 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
US6077668A
(en)
*
|
1993-04-15 |
2000-06-20 |
University Of Rochester |
Highly sensitive multimeric nucleic acid probes
|
US5648211A
(en)
*
|
1994-04-18 |
1997-07-15 |
Becton, Dickinson And Company |
Strand displacement amplification using thermophilic enzymes
|
US5854033A
(en)
*
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
AU704750B2
(en)
*
|
1995-12-05 |
1999-05-06 |
Jorn Erland Koch |
A cascade nucleic acid amplification reaction
|
GB9609213D0
(en)
*
|
1996-05-02 |
1996-07-03 |
Tepnel Medical Ltd |
Amplification of nucleic acids
|
JP3415995B2
(ja)
*
|
1996-06-10 |
2003-06-09 |
科学技術振興事業団 |
高分子マイクロ遺伝子重合体の作成方法
|
GB9626074D0
(en)
*
|
1996-12-16 |
1997-02-05 |
Cytocell Ltd |
Nucleic acids amplification assay
|
EP1985714B1
(en)
*
|
1998-03-25 |
2012-02-29 |
Olink AB |
Method and kit for detecting a target molecule employing at least two affinity probes and rolling circle replication of padlock probes
|
US6316229B1
(en)
|
1998-07-20 |
2001-11-13 |
Yale University |
Single molecule analysis target-mediated ligation of bipartite primers
|
WO2000015779A2
(en)
*
|
1998-09-15 |
2000-03-23 |
Yale University |
Molecular cloning using rolling circle amplification
|
JP2002525078A
(ja)
*
|
1998-09-15 |
2002-08-13 |
イェール ユニバーシティ |
人工的長末端反復配列
|
WO2000022163A2
(de)
*
|
1998-10-12 |
2000-04-20 |
Attomol Gmbh Molekulare Diagnostika |
Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen
|
GB9822777D0
(en)
*
|
1998-10-20 |
1998-12-16 |
Tepnel Medical Ltd |
Template chain reaction
|
US6830884B1
(en)
|
1998-12-15 |
2004-12-14 |
Molecular Staging Inc. |
Method of amplification
|
US20020025519A1
(en)
|
1999-06-17 |
2002-02-28 |
David J. Wright |
Methods and oligonucleotides for detecting nucleic acid sequence variations
|
NZ518320A
(en)
|
1999-10-18 |
2003-10-31 |
Prince Henrys Inst Med Res |
Immuno-interactive fragments of the alphaC subunit of inhibin
|
WO2001040516A2
(en)
*
|
1999-12-02 |
2001-06-07 |
Molecular Staging Inc. |
Generation of single-strand circular dna from linear self-annealing segments
|
CN1419564A
(zh)
|
2000-01-25 |
2003-05-21 |
昆士兰大学 |
包含脑膜炎奈瑟氏球菌表面抗原NhhA的保守区域的蛋白质
|
US6221603B1
(en)
*
|
2000-02-04 |
2001-04-24 |
Molecular Dynamics, Inc. |
Rolling circle amplification assay for nucleic acid analysis
|
AU2001238106A1
(en)
*
|
2000-02-10 |
2001-08-20 |
The Penn State Research Foundation |
Method for amplifying full length single strand polynucleotide sequences
|
US6291187B1
(en)
|
2000-05-12 |
2001-09-18 |
Molecular Staging, Inc. |
Poly-primed amplification of nucleic acid sequences
|
US6323009B1
(en)
|
2000-06-28 |
2001-11-27 |
Molecular Staging, Inc. |
Multiply-primed amplification of nucleic acid sequences
|
AU7172201A
(en)
|
2000-06-30 |
2002-01-14 |
Molecular Staging Inc |
Signal amplification with lollipop probes
|
US6312913B1
(en)
*
|
2000-07-21 |
2001-11-06 |
Incyte Genomics, Inc. |
Method for isolating and characterizing nucleic acid sequences
|
AUPR030900A0
(en)
|
2000-09-22 |
2000-10-12 |
Queensland University Of Technology |
Growth factor complex
|
US6573051B2
(en)
|
2001-03-09 |
2003-06-03 |
Molecular Staging, Inc. |
Open circle probes with intramolecular stem structures
|
AUPR446701A0
(en)
|
2001-04-18 |
2001-05-17 |
Gene Stream Pty Ltd |
Transgenic mammals for pharmacological and toxicological studies
|
US7838270B2
(en)
|
2001-05-22 |
2010-11-23 |
The University Of Chicago |
Target-dependent transcription using deletion mutants of N4 RNA polymerase
|
GB2378245A
(en)
|
2001-08-03 |
2003-02-05 |
Mats Nilsson |
Nucleic acid amplification method
|
CA2490261A1
(en)
|
2002-06-27 |
2004-01-08 |
The University Of Queensland |
Differentiation modulating agents and uses therefor
|
AU2003900481A0
(en)
|
2003-02-05 |
2003-02-20 |
Queensland University Of Technology |
Synthetic modulators of cell migration and growth
|
US20100143442A1
(en)
|
2003-02-05 |
2010-06-10 |
Queensland University Of Technology |
Growth factor complexes and modulation of cell migration and growth
|
WO2011063477A1
(en)
|
2009-11-30 |
2011-06-03 |
Queensland University Of Technology |
Fibronectin: growth factor chimeras
|
US8043834B2
(en)
|
2003-03-31 |
2011-10-25 |
Qiagen Gmbh |
Universal reagents for rolling circle amplification and methods of use
|
AU2003902253A0
(en)
|
2003-05-12 |
2003-05-29 |
The University Of Queensland |
Method for increasing product yield
|
WO2005108608A1
(en)
*
|
2004-05-10 |
2005-11-17 |
Kabushiki Kaisha Dnaform |
Method for isolating nucleic acid isoforms
|
US7960513B2
(en)
|
2004-12-17 |
2011-06-14 |
Monash University |
Antibody against a human ADAM protease
|
US8916351B2
(en)
|
2005-01-04 |
2014-12-23 |
Hitachi Chemical Co., Ltd. |
Primer generation rolling circle amplification
|
GB0504774D0
(en)
*
|
2005-03-08 |
2005-04-13 |
Lingvitae As |
Method
|
US8309303B2
(en)
|
2005-04-01 |
2012-11-13 |
Qiagen Gmbh |
Reverse transcription and amplification of RNA with simultaneous degradation of DNA
|
US7989166B2
(en)
|
2005-04-12 |
2011-08-02 |
In Situ Rcp A/S |
Circle probes and their use in the identification of biomolecules
|
EP1871897B1
(en)
|
2005-04-12 |
2010-09-29 |
Olink AB |
Methods for production of oligonucleotides
|
WO2006138257A2
(en)
|
2005-06-15 |
2006-12-28 |
Callida Genomics, Inc. |
Single molecule arrays for genetic and chemical analysis
|
EP1762627A1
(de)
|
2005-09-09 |
2007-03-14 |
Qiagen GmbH |
Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
|
ATE537251T1
(de)
|
2005-10-06 |
2011-12-15 |
Lucigen Corp |
Temperaturstabile virale polymerasen und verwendungsverfahren
|
US7960104B2
(en)
*
|
2005-10-07 |
2011-06-14 |
Callida Genomics, Inc. |
Self-assembled single molecule arrays and uses thereof
|
SG10201405158QA
(en)
*
|
2006-02-24 |
2014-10-30 |
Callida Genomics Inc |
High throughput genome sequencing on dna arrays
|
US7501254B2
(en)
|
2006-07-20 |
2009-03-10 |
Ghc Technologies, Inc. |
Methods and compositions for amplification and capture of nucleic acid sequences
|
KR20090046876A
(ko)
|
2006-08-31 |
2009-05-11 |
도요 세이칸 가부시키가이샤 |
핵산의 증폭방법
|
US7910302B2
(en)
|
2006-10-27 |
2011-03-22 |
Complete Genomics, Inc. |
Efficient arrays of amplified polynucleotides
|
EP2162554A4
(en)
|
2007-05-31 |
2010-07-28 |
Univ Queensland |
DIAGNOSTIC MARKERS FOR ANKYLOSING SPONDYLARTHRITIS AND USES THEREOF
|
GB0901593D0
(en)
|
2009-01-30 |
2009-03-11 |
Touchlight Genetics Ltd |
Production of closed linear DNA
|
GB201013153D0
(en)
|
2010-08-04 |
2010-09-22 |
Touchlight Genetics Ltd |
Primer for production of closed linear DNA
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
LT3590949T
(lt)
|
2010-10-01 |
2022-07-25 |
Modernatx, Inc. |
Ribonukleorūgštys, kurių sudėtyje yra n1-metil-pseudouracilų, ir jų naudojimas
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
MX354267B
(es)
|
2011-10-03 |
2018-02-21 |
Moderna Therapeutics Inc Star |
Nucléosidos, nucleótidos, y ácidos nucleicos modificados, y usos de los mismos.
|
US20130156849A1
(en)
|
2011-12-16 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
CA2868996A1
(en)
|
2012-04-02 |
2013-10-10 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
WO2014076209A1
(en)
|
2012-11-14 |
2014-05-22 |
Olink Ab |
Localised rca-based amplification method
|
HRP20220607T1
(hr)
|
2012-11-26 |
2022-06-24 |
Modernatx, Inc. |
Terminalno modificirana rna
|
EP3564370B1
(en)
|
2013-03-15 |
2022-01-12 |
Labrador Diagnostics LLC |
Nucleic acid amplification
|
US10450595B2
(en)
|
2013-03-15 |
2019-10-22 |
Theranos Ip Company, Llc |
Nucleic acid amplification
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
US9416387B2
(en)
|
2013-03-15 |
2016-08-16 |
Theranos, Inc. |
Nucleic acid amplification
|
WO2014145296A2
(en)
|
2013-03-15 |
2014-09-18 |
Theranos, Inc. |
Nuclei acid amplification
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
MX356055B
(es)
|
2013-09-06 |
2018-05-11 |
Theranos Ip Co Llc |
Sistemas y métodos para detectar enfermedades infecciosas.
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
EA201690675A1
(ru)
|
2013-10-03 |
2016-08-31 |
Модерна Терапьютикс, Инк. |
Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
|
GB201321123D0
(en)
|
2013-11-29 |
2014-01-15 |
Linea Ab Q |
Amplification of circular molecules
|
US10758558B2
(en)
|
2015-02-13 |
2020-09-01 |
Translate Bio Ma, Inc. |
Hybrid oligonucleotides and uses thereof
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
JP6624704B2
(ja)
|
2015-08-31 |
2019-12-25 |
日立化成株式会社 |
尿路上皮疾患の評価のための分子法
|
GB201614023D0
(en)
|
2016-08-16 |
2016-09-28 |
Olink Bioscience Ab |
Double-stranded circle probes
|
US11524066B2
(en)
|
2016-12-23 |
2022-12-13 |
CureVac SE |
Henipavirus vaccine
|
EP3558356A2
(en)
|
2016-12-23 |
2019-10-30 |
CureVac AG |
Mers coronavirus vaccine
|
WO2018115525A1
(en)
|
2016-12-23 |
2018-06-28 |
Curevac Ag |
Lassa virus vaccine
|
JP2020514370A
(ja)
|
2017-03-17 |
2020-05-21 |
キュアバック アーゲー |
組合せ抗癌療法のためのrnaワクチン及び免疫チェックポイント阻害剤
|
US11739389B2
(en)
|
2017-05-17 |
2023-08-29 |
Microbio Pty Ltd |
Biomarkers and uses thereof
|
CN111328287A
(zh)
|
2017-07-04 |
2020-06-23 |
库瑞瓦格股份公司 |
新型核酸分子
|
JP2021508490A
(ja)
|
2017-12-15 |
2021-03-11 |
フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー |
環状ポリリボヌクレオチドを含む組成物及びその使用
|
US20210361761A1
(en)
|
2018-04-05 |
2021-11-25 |
Curevac Ag |
Novel yellow fever nucleic acid molecules for vaccination
|
CN112292395A
(zh)
|
2018-04-17 |
2021-01-29 |
库瑞瓦格股份公司 |
用于疫苗接种的新型rsv rna分子和组合物
|
WO2020002525A1
(en)
|
2018-06-27 |
2020-01-02 |
Curevac Ag |
Novel lassa virus rna molecules and compositions for vaccination
|
US20220040281A1
(en)
|
2018-12-21 |
2022-02-10 |
Curevac Ag |
Rna for malaria vaccines
|
US20220133908A1
(en)
|
2019-02-08 |
2022-05-05 |
Curevac Ag |
Coding rna administered into the suprachoroidal space in the treatment of ophthalmic diseases
|
IL285951B1
(en)
|
2019-03-01 |
2024-04-01 |
Flagship Pioneering Innovations Vi Llc |
Polyribonucleotides and their cosmetic uses
|
CA3128615A1
(en)
|
2019-03-01 |
2020-09-10 |
Flagship Pioneering Innovations Vi, Llc |
Topical delivery of polyribonucleic acids
|
CN113544269A
(zh)
|
2019-03-04 |
2021-10-22 |
旗舰创业创新第六有限责任公司 |
环状多核糖核苷酸及其药物组合物
|
KR20210142678A
(ko)
|
2019-03-25 |
2021-11-25 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
변형된 원형 폴리리보뉴클레오티드를 포함하는 조성물 및 그의 용도
|
CN114007655A
(zh)
|
2019-06-14 |
2022-02-01 |
旗舰创业创新第六有限责任公司 |
用于细胞疗法的环状rna
|
EP3986469A1
(en)
|
2019-06-19 |
2022-04-27 |
Flagship Pioneering Innovations VI, LLC |
Compositions comprising circular polyribonucleotides for protein modulation and uses thereof
|
WO2020257727A1
(en)
|
2019-06-19 |
2020-12-24 |
Flagship Pioneering Innovations Vi, Llc |
Methods of dosing circular polyribonucleotides
|
JP2022544412A
(ja)
|
2019-08-14 |
2022-10-18 |
キュアバック アーゲー |
免疫賦活特性が減少したrna組み合わせおよび組成物
|
CN115361954A
(zh)
|
2020-01-29 |
2022-11-18 |
旗舰创业创新第六有限责任公司 |
用于翻译的组合物及其使用方法
|
EP4096681A1
(en)
|
2020-01-29 |
2022-12-07 |
Flagship Pioneering Innovations VI, LLC |
Delivery of compositions comprising circular polyribonucleotides
|
JP2023526423A
(ja)
|
2020-05-20 |
2023-06-21 |
フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー |
免疫原性組成物及びその使用
|
JP2023526422A
(ja)
|
2020-05-20 |
2023-06-21 |
フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー |
コロナウイルス抗原組成物及びそれらの使用
|
US20230203192A1
(en)
|
2020-05-20 |
2023-06-29 |
Flagship Pioneering, Inc. |
Compositions and methods for producing human polyclonal antibodies
|
JP2023542492A
(ja)
|
2020-09-03 |
2023-10-10 |
フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー |
免疫原性組成物及びその使用
|
WO2022066757A1
(en)
|
2020-09-23 |
2022-03-31 |
Myeloid Therapeutics, Inc. |
Improved methods and compositions for expression of nucleic acids in cells
|
EP4240367A2
(en)
|
2020-11-04 |
2023-09-13 |
Myeloid Therapeutics, Inc. |
Engineered chimeric fusion protein compositions and methods of use thereof
|
AU2022397292A1
(en)
|
2021-11-24 |
2024-05-30 |
Flagship Pioneering Innovations Vi, Llc |
Varicella-zoster virus immunogen compositions and their uses
|
WO2023096990A1
(en)
|
2021-11-24 |
2023-06-01 |
Flagship Pioneering Innovation Vi, Llc |
Coronavirus immunogen compositions and their uses
|
WO2023097003A2
(en)
|
2021-11-24 |
2023-06-01 |
Flagship Pioneering Innovations Vi, Llc |
Immunogenic compositions and their uses
|
WO2023115013A1
(en)
|
2021-12-17 |
2023-06-22 |
Flagship Pioneering Innovations Vi, Llc |
Methods for enrichment of circular rna under denaturing conditions
|
TW202340461A
(zh)
|
2021-12-22 |
2023-10-16 |
美商旗艦先鋒創新有限責任公司 |
用於純化多核糖核苷酸之組成物和方法
|
TW202342064A
(zh)
|
2021-12-23 |
2023-11-01 |
美商旗艦先鋒創新有限責任公司 |
編碼抗融合多肽之環狀多核糖核苷酸
|
WO2024097664A1
(en)
|
2022-10-31 |
2024-05-10 |
Flagship Pioneering Innovations Vi, Llc |
Compositions and methods for purifying polyribonucleotides
|